九州大学大学院医学研究院神経内科学教室

menu

ACTIVITY REPORT活動報告

研究業績

2019年度業績

  • Watanabe M, Nakamura Y, Michalak Z, Isobe N, Barro C, Leppert D, Matsushita T, Hayashi F, Yamasaki R, Kuhle J, Kira J: Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 93(13): e1299-e1311, 2019. (IF=8.689)
  • Maimaitijang G, Watanabe M, Shinoda K, Isobe N, Nakamura Y, Masaki K, Matsushita T, Yoshikai Y, Kira J: Long-term use of interferon-β in multiple sclerosis increases Vδ1-Vδ2-Vɤ29-ɤδ T cells that are associated with a better outcome. J Neuroinflamm 16:179, 2019. (IF=5.700)
  • Ogata H*, Zhang X*, Yamasaki R, Fujii T, Machida A, Morimoto N, Kaida K, Masuda T, Ando Y, Kuwahara M, Kusunoki S, Nakamura Y, Matsushita T, Isobe N, Kira J: Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody. Ann Clin Transl Neurol 6(11): 2304-2316, 2019. *Equal contribution. (IF=4.656)
  • Cui YW*, Masaki K*, Zhang X, Yamasaki R, Fujii T, Ogata H, Hayashida S, Yamaguchi H, Hyodo F, Eto H, Koyama S, Iinuma K, Yonekawa T, Matsushita T, Yoshida M, Yamada K, Kawano M, Mailssen M, Mailssen B, Kira J: A novel model for treatment of hypertrophic pachymeningitis. Ann Clin Transl Neurol 6(3): 431–444, 2019. *Equal contribution. (IF=4.656)
  • Zhang X, Fujii T, Ogata H, Yamasaki R, Masaki K, Cui YW, Matsushita T, Isobe N, Kira J: Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis. J Neuroimmunol 330: 38-43, 2019. (IF=2.832)
  • Saitoh B, Yamasaki R, Hiwatashi A, Matsushita T, Hayashi S, Mitsunaga Y, Maeda Y, Isobe N, Yoshida K, Ikeda S, Kira J: Discriminative clinical and neuroimaging features of motor-predominant hereditary diffuse leukoencephalopathy with axonal spheroids and primary progressive multiple sclerosis: a preliminary cross-sectional study. Mult Scler Relat Disord 31: 22-31, 2019. (IF=2.725)
  • Barcelon EA, Mukaino T, Yokoyama J, Uehara T, Ogata K, Kira J, Tobimatsu S: Grand total EEG score can differentiate Parkinson’s disease from Parkinson-related disorders. Front Neurol 10: 398, 2019. (IF=2.635)
  • Shimmura M, Uehara T, Ogata K, Shigeto M, Maeda T, Sakata A, Yamasaki R, Kira J: Higher postictal parasympathetic activity following greater ictal heart rate increase in right than left-sided seizures. Epilepsy Behav 97:161-168, 2019. (IF=2.378)
  • Tanaka K, Matsumoto S, Yamada T, Nagano S, Takase K, Hatano T, Yamasaki R, Kira J: Temporal trends in clinical characteristics and door-to-needle time in patients receiving intravenous tissue plasminogen activator: a retrospective study of four hospitals in Japan. J Stroke and Cerebrovascular Dis 28(11): 104305, 2019. (IF=1.646)
  • Baba T, Shinoda K, Watanabe M, Sadashima S, Matsuse D, Isobe N, Yamasaki R, Kaneko K, Takahashi T, Iwaki T, Kira J: MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis. Mult Scler Relat Disord 30: 48-50, 2019. (IF=2.725)
  • Mizuno Y, Shinoda K, Watanabe M, Ogata H, Isobe N, Matsushita T, Yamasaki R, Tanaka K, Koike H, Katsuno M, Kira J: Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: a case report. Mult Scler Relat Disord 35:16-18, 2019. (IF=2.725)
  • Fujii T, Takase K, Honda H, Kawamura N, Yamasaki R, Urata M, Uchiumi T, Iwaki T, Kira J: Toxic myopathy with multiple deletions in mitochondrial DNA associated with long-term use of oral anti-viral drugs for hepatitis B. Neuropathology 39(2):162-167, 2019. (IF=2.161)
  • Isobe N, Baba T, Nakamura Y, Shinoda K, Watanabe M, Matsushita T, Kira J: Case of central nervous system inflammatory disease in late pregnancy. Clin Exp Neuroimmunol 10: 54-58, 2019. (IFなし)
  • Okadome T, Uehara T, Shinoda K, Yamashita K, Murai H, Isobe N, Yamasaki R, Kira J: Creutzfeldt-Jakob disease-like diffusion-weighted imaging hyperintensity paralleled with neuropsychiatric symptoms in a patient with limbic encephalitis associated with anti-voltage-gated potassium channel complex antibodies. Clin Exp Neuroimmunol 10(3):204-206, 2019. (IFなし)
  • Yokoyama J, Yamaguchi H, Kohge J, Matsuhshita T, Isobe N, Yamasaki R, Kira J: Brainstem posterior reversible encephalopathy syndrome in a case with Guillain-Barré syndrome. Clin Exp Neuroimmunol 10(4):267-271, 2019. (IFなし)
  • Kira J, Isobe N: Helicobacter pylori infection and demyelinating disease of the central nervous system. J Neuroimmunol 329:14-19, 2019. (IF=2.832)
  • Fujii T, Honda H, Yamasaki R, Iwaki T, Kira J: Multiple mt DNA deletions due to mitochondrion-toxicity of anti-hepadnavirul drugs: comments to the letter from Finsterer J. Neuropathology 39(4): 326-327, 2019. (IF=2.161)
  • Fujii T, Yamasaki R, Kira J: Anti-plexin D1 antibodies are a novel biomarker for immune-mediated neuropathic pain. Clin Exp Neuroimmunol 10(1): 7-8, 2019. (IFなし)
  • Kira J, Isobe N: Multiple sclerosis, Neuroimmune diseases; from cells to the living brain. Mitoma H, Manto M (Eds). Springer pp. 487-521, 2019. (IFなし)
  • Yamasaki R, Kira J: Multiple Sclerosis. Myelin – Basic and Clinical Advances. Sango K, Yamauchi J, Ogata T, Susuki K (Eds.). Springer pp. 217-247, 2019. (IFなし)
  • 吉良 潤一：長期での疾患活動性の再燃　今後の検証課題．The Mainichi Medical Journal 15(3): 75
  • 吉良 潤一：多発性硬化症．今日の治療指針2019年版-私はこう治療している．医学書院　pp. 941-944, 2019．
  • 吉良 潤一：中枢神経系脱髄疾患．内科学書　9版 vol.6 南学正臣、伊藤裕、大田健、小澤敬也、下村伊一郎、田中章景、千葉勉、伴信太郎、平井豊博、深川雅史、福田恵一、藤田次郎、三森経世、持田智、山田俊幸、山本和利、塩沢昌英 (編集)．中山書店　pp.401-404, 2019.
  • 眞﨑 勝久、吉良 潤一：IgG4関連疾患と肥厚性硬膜炎．脳神経内科, 2019
  • 渡邉 充、吉良 潤一：ミエリンベーシック蛋白（MBP）．内科, 2019．
  • 渡邉 充、吉良 潤一：神経免疫療法．標準的医療説明の手順書 2019年版．「説明と同意」委員会, 一般社団法人内科系学会社会保険連合, 東京. pp134-139, 2019.（査読なし）
  • 渡邉 充：多発性硬化症と類縁疾患．ディサースリア臨床研究 9(1):46-52, 2019
  • 藤井 敬之、吉良 潤一：アトピー性脊髄炎．日本医師会雑誌「指定難病ペディア2019」第148巻・特別号(１)・(生涯教育シリーズ96) , 2019．
  • 藤井 敬之、吉良 潤一：神経疾患治療ノート．脊髄炎・アトピー性脊髄炎．Clinical Neuroscience vol.37 no.7．中外医学社, pp.880-881, 2019．
  • 藤井 敬之、吉良 潤一：アトピー性脊髄炎．指定難病ペディア2019．水澤英洋、五十嵐隆、北川泰久、高橋和久、弓倉整（監修・編集）日本医師会　pp. S113, 2019．
  • 福元 尚子、吉良 潤一：日本人多発性硬化症患者のフィンゴモリド使用．難病と在宅ケア, 2019．
  • 岩木 三保、吉良 潤一：指定難病制度(5)　一患者支援体制．日本医師会雑誌「指定難病ペディア2019」第148巻・特別号(１)・(生涯教育シリーズ96), 2019．
  • 岩木 三保、吉良 潤一：指定難病制度(5)．患者支援体制．指定難病ペディア 2019．水澤英洋、五十嵐隆、北川泰久、高橋和久、弓倉整（監修・編集）日本医師会　pp. S46-48, 2019．

過去の業績

Page Top